This Systems of Care III OUD/SUD Learning Collaborative is a highly interactive webinar, that will provide a brief overview of the current trends in use of high potency synthetic opioids, xylazine, and the most common novel psychoactive substances,synthetic cannabinoids. In greater detail this webinar will discuss the recent trends in fentanyl use and address xylazine and how it is affecting harm reduction messages, overdose response, and medication for opioid use disorder (MOUD) initiation.
